thassodotcom
Posted in New Research, On The Horizon, Personalized Medicine, Personomics, Targeted Therapy, Thasso Post, Theragenomic Medicine
No Comments ↓
July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019.
Blockchain as an emerging technology (particularly around the hype on Bitcoins) has been gaining in popularity,
…
thassodotcom
Posted in Clinical Development, Digital Health, Genetic Background, Genetic Predisposition, In The Press, Neue Forschung, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
June 13, 2019 – This is simply fascinating stuff. Researchers are testing neural networks that automatically combine portrait photos with genetic and phenotypic patient data in order to obtain definitive diagnosis of hereditary rare diseases, all with the help of artificial intelligence (AI).
…
thassodotcom
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, Genetic Susceptibility, New Research, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
May 13, 2018 – Researchers have uncovered 17 genetic variants linked to different depression-related phenotypes in a large genome-wide association study, including variants near genes involved in neurotransmission and synapse function.
The first author of the study, David Howard, Center for Clinical Brain Sciences, University of Edinburgh,
…
thassodotcom
Posted in Adverse Drug Reaction [ADR], In The Press, New Research, On The Horizon, Personalized Medicine, Thasso Post, Theragenomic Medicine
No Comments ↓
May 04, 2018 – All natural is healthy. This is a common belief for many, particularly when shopping for alternative medicines and dietary supplements. For many, however, the contrary might be fatally true.
As a point in case, new research shows, that substances in Traditional Chinese Medicine (TCM) can cause severe cardiac arrhythmia.
…
thassodotcom
Posted in Genetic Background, Genetic Predisposition, New Research, On The Horizon, Personalized Medicine, Placebo, Thasso Post, Theragenomic Medicine
No Comments ↓
February 11, 2018 – Long after cancer treatment ends, many patients continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers have found that the power of placebos, even when fully disclosed to patients, might be harnessed to reduce fatigue in cancer survivors.
…
thassodotcom
Posted in Allelic Variant, Genetic Background, New Research, On The Horizon, Placebo, Thasso Post, Theragenomic Medicine
No Comments ↓
…
thassodotcom
Posted in Allelic Variant, Genetic Background, New Research, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
November 20, 2017 – Thanks to old aged Amish people, the first ever anti-ageing genetic mutation(s) have been discovered. According to a study published in the Journal Science Advances revealed a research team from a Northwestern University Feinberg School of Medicine, Chicago, IL, USA that seemingly an Indiana Amish
community holds the (genetic) key to living about 10% longer.
…
thassodotcom
Posted in Children, Gene Therapy, Genetic Background, Genetic Predisposition, New Research, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
November 12, 2017 – Spinal muscular atrophy type 1 (SMA1) is a progressive, monogenic motor neuron disease with an onset during infancy that results in failure to achieve motor milestones and in death or the need for mechanical ventilation by 2 years of age.
…
thassodotcom
Posted in New Research, On The Horizon, Personalized Medicine, Targeted Therapy, Thasso Post, Theragenomic Medicine
No Comments ↓
November 05, 2017 – For some patients knowingly or not knowingly suffering from depression, the upcoming period of the year (i.e., the winter season in the Northern Hemisphere) with grey days and over-porportionally long nights, might be a difficult one. Should such patients enter a antidepressant treatment,
…
thassodotcom
Posted in Adverse Drug Reaction [ADR], New Safety Information, On The Horizon, Regulatory Announcement, Thasso Post, Theragenomic Medicine
No Comments ↓
November 01, 2017 – According to the watch list of the American Food & Drug Administration (FDA) for drugs with possible safety issues from January to March 2016,
the FDA was looking at the possible link between various drugs in the phosphodiesterase-5 (PDE-5) inhibitors class and melanoma as a serious adverse effect.
…
Optional: Social Subscribe/Login
thasso: recent comments